Most patients under routine glaucoma care demonstrate slow rates of visual field progression. The MD rate in the current study was similar to an interventional prospective study, but considerably less negative compared to published studies with similar design.
An understanding of the relationship between functional and structural measures in primary open angle glaucoma (POAG) is necessary for both grading the severity of disease and for understanding the natural history of the condition. This article outlines the current evidence for the nature of this relationship, and highlights the current mathematical models linking structure and function. Large clinical trials demonstrate that both structural and functional change are apparent in advanced stages of disease, while, at an individual level, detectable structural abnormality may precede functional abnormality in some patients whilst the converse in true in other patients. Although the exact nature of the ‘structure-function’ relationship in POAG is still the topic of scientific debate and the subject of continuing research, this article aims to provide the clinician with an understanding of the past concepts and contemporary thinking in relation to the structure-function relationship in POAG.
PURPOSE. Evaluation of progressive visual field (VF) damage is often based on pointwise sensitivity data from standard automated perimetry; however, frequency-of seeing and test-retest studies demonstrate that these measurements can be highly variable, especially in areas of damage. The aim of this study was to characterize VF variability by the level of sensitivity using a statistical method to quantify heteroscedasticity.
METHODS.A total of 14,887 Humphrey 24-2 SITA Standard VFs from 2736 patients (2736 eyes) attending Moorfields Eye Hospital from 1997 to 2009 were studied retrospectively. The VF series of each eye was analyzed using pointwise linear regression of sensitivity over time, with residuals (difference from fitted-value) from each regression pooled according to both observed and fitted sensitivities.
RESULTS.The median (interquartile range) patient age, follow-up, and series length was 64 (54-71) years, 5.5 (3.9-7.0) years, and 6 (5-7) VFs, respectively. The inferred variability as a function of fitted-sensitivity was in good agreement with previous estimates. Variability was also described as a function of measured sensitivity, which confirmed that variability increased rapidly as the observed sensitivity decreased.CONCLUSIONS. This study highlights a new approach for characterizing VF variability by the level of sensitivity. A considerable strength of the method is that inference is based on thousands of clinic patients rather than the tens of subjects in test-retest studies. The results can help distinguish real VF progression from measurement variability and will be used in models for glaucoma progression detection. (Invest Ophthalmol Vis Sci. 2012;53:5985-5990)
BLR provides a significantly more accurate estimate of the rate of change in MS than the standard OLSLR approach, especially in short time series, suggesting that structural measurements can be used successfully in statistical models to assist clinicians monitoring VF progression in patients with OHT. Further studies are necessary to validate the method in glaucoma patients.
This is the accepted version of the paper.This version of the publication may differ from the final published version. Results One-hundred and four patients with COAG were included. 73 patients had at least 2 years of follow-up. Median (IQR) total number of VF tests and in the first 2 years of diagnosis were 4 (2-7) and 2 (2-3), respectively. No patients met EGS guidelines, but 87% of patients had their monitoring intervals requested in accordance with NICE guidelines. These intervals were not related to disease severity or VF stability (KruskalWallis test, p=0.25) but shortened significantly when IOP control was inadequate or when the overall clinical impression was disease progression ( p<0.001).
Permanent repository linkConclusions Most newly-diagnosed COAG patients receive less than three VFs in the first 2 years following diagnosis and an average of 0.7 VF per year over the duration of follow-up.
PurposeTo compare conventional structural and functional measures of glaucomatous damage with a new functional measure—contrast sensitivity perimetry (CSP-2).MethodsOne eye each was tested for 51 patients with glaucoma and 62 age-similar control subjects using CSP-2, size III 24-2 conventional automated perimetry (CAP), 24-2 frequency-doubling perimetry (FDP), and retinal nerve fiber layer (RNFL) thickness. For superior temporal (ST) and inferior temporal (IT) optic disc sectors, defect depth was computed as amount below mean normal, in log units. Bland-Altman analysis was used to assess agreement on defect depth, using limits of agreement and three indices: intercept, slope, and mean difference. A criterion of p < 0.0014 for significance used Bonferroni correction.ResultsContrast sensitivity perimetry-2 and FDP were in agreement for both sectors. Normal variability was lower for CSP-2 than for CAP and FDP (F > 1.69, p < 0.02), and Bland-Altman limits of agreement for patient data were consistent with variability of control subjects (mean difference, −0.01 log units; SD, 0.11 log units). Intercepts for IT indicated that CSP-2 and FDP were below mean normal when CAP was at mean normal (t > 4, p < 0.0005). Slopes indicated that, as sector damage became more severe, CAP defects for IT and ST deepened more rapidly than CSP-2 defects (t > 4.3, p < 0.0005) and RNFL defects for ST deepened more slowly than for CSP, FDP, and CAP. Mean differences indicated that FDP defects for ST and IT were on average deeper than RNFL defects, as were CSP-2 defects for ST (t > 4.9, p < 0.0001).ConclusionsContrast sensitivity perimetry-2 and FDP defects were deeper than CAP defects in optic disc sectors with mild damage and revealed greater residual function in sectors with severe damage. The discordance between different measures of glaucomatous damage can be accounted for by variability in people free of disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.